Pharmacoeconomics of therapy for ITP: steroids, IVIg, anti-D, and splenectomy-Reference-Cited by-同舟云学术

Pharmacoeconomics of therapy for ITP: steroids, IVIg, anti-D, and splenectomy

Published:2002-03 Issue:1 Volume:16 Page:65-67
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Adams J.R.,Nathan D.P.,Bennett C.L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference9 articles.

1. Idiopathic thrombocytopenic purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy;Simpson;Semin Hematol,1998

2. Management of idiopathic thrombocytopenic purpura in adults;McVerry;Br J Haematol,1985

3. Intravenous anti-D treatment of immune thrombocytopenia purpura: Experience in 272 patients;Scaradavou;Blood,1997

4. The cost of treating immune thrombocytopenic purpura using intravenous Rh immune globulin versus intravenous immune globulin;Sandler;Am J Hematol,2000

5. Medical Economics Inc. 2000 Red Book, August 2001 update, Montvale, New Jersey, Medical Economics Company, Inc. 2000

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune thrombocytopenia: options and new perspectives;Blood Coagulation & Fibrinolysis;2021-07-01

2. Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate;Annals of Hematology;2010-09-15

3. Management of Chronic Childhood Immune Thrombocytopenic Purpura: AIEOP Consensus Guidelines;Acta Haematologica;2010

4. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura;Blood;2008-11-15

5. Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac®) in chronic immune thrombocytopenic purpura;Hematology;2007-08